Home |
Free Dividend Report |
Stock Splits Calendar |
ALLO Stock Split History |
Preferred Stock Newsletter |
ALLO Options Chain |
Stock Message Boards |
Allogene Therapeutics (ALLO) has 0 splits in our Allogene Therapeutics stock split history database.
Looking at the Allogene Therapeutics stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Allogene Therapeutics shares, starting with a $10,000 purchase of ALLO, presented on a split-history-adjusted basis factoring in the complete Allogene Therapeutics stock split history.
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 10/12/2018 | |
End date: | 05/01/2024 | |
Start price/share: | $26.81 | |
End price/share: | $2.92 | |
Dividends collected/share: | $0.00 | |
Total return: | -89.11% | |
Average Annual Total Return: | -32.90% | |
Starting investment: | $10,000.00 | |
Ending investment: | $1,089.54 | |
Years: | 5.56 |
About Allogene Therapeutics |
Allogene Therapeutics is a clinical stage immuno-oncology company focused on the development of genetically engineered allogeneic T cell therapies for the treatment of cancer. Co.'s key product candidates, ALLO-501 and ALLO-501A, are engineered allogeneic Chimeric antigen receptor (CAR) T cell therapies that target CD19, a protein expressed on the cell surface of B cells and a validated target for B cell driven hematological malignancies. Co. is also developing engineered allogeneic CAR T cell product candidates for multiple myeloma, clear cell renal cell carcinoma, and other blood cancers and solid tumors. According to our Allogene Therapeutics stock split history records, Allogene Therapeutics has had 0 splits. |
ALLO Split History Table | |
Date | Ratio |
Allogene Therapeutics Stock Split History | www.StockSplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved
Nothing in www.StockSplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?
Want to receive our latest research absolutely free?
⤹
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.